Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017

The decline in the proportion of pneumococcal conjugate vaccine (PCV)–covered serotypes among adult invasive pneumococcal disease (IPD) patients might change the overall effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) because its effectiveness differs according to serotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimbashi, Reiko, Suzuki, Motoi, Chang, Bin, Watanabe, Hiroshi, Tanabe, Yoshinari, Kuronuma, Koji, Oshima, Kengo, Maruyama, Takaya, Takeda, Hiroaki, Kasahara, Kei, Fujita, Jiro, Nishi, Junichiro, Kubota, Tetsuya, Tanaka-Taya, Keiko, Matsui, Tamano, Sunagawa, Tomimasa, Oishi, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510723/
https://www.ncbi.nlm.nih.gov/pubmed/32946721
http://dx.doi.org/10.3201/eid2610.191531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510723/
https://www.ncbi.nlm.nih.gov/pubmed/32946721
http://dx.doi.org/10.3201/eid2610.191531

Ejemplares similares